LDL-C Manager helps clinicians reduce ASCVD risk by managing LDL-C. The app guides clinicians through one continuous lipid-lowering process by linking the ASCVD Risk Estimator, Statin Intolerance app, and the brand new Lipid-Lowering Therapy tool based on the 2016 Role of Non-Statin Therapies Expert Consensus Decision Pathway and the 2017 Focused Update to this document, based on recent clinical trials including FOURIER.
Input individualized patient data to:
- Estimate ASCVD risk
- Review customized lifestyle and statin initiation advice
- Assess patient-specific response to lipid-lowering therapy
- Determine when and which non-statin therapies should be considered
Email yourself a detailed report of all assessments conducted within the app.
Advice from the app is derived from official ACC clinical policy documents including the 2013 ACC/AHA Guidelines on the Assessment of Cardiovascular Risk and The Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults, and the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk, and the 2017 Focused Update to the Pathway. The information and recommendations in this app are meant to support clinical decision making. They are not meant to represent the only or best course of care, or replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider.
This was developed as part of the ACC's Lipid Management Solutions Initiative. Financial support for the Initiative was provided by Amgen Inc. All of the content was independently developed with no sponsor involvement.
We want to hear from you!
Help the ACC find new and better ways to deliver guideline content to clinicians. Share your feedback:
- Complete a feedback survey
- Leave comments on the App’s iTunes or Google Play page